# A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy

> **NCT06510114** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 150 (estimated)

## Conditions studied

- Graves Ophthalmopathy

## Interventions

- **DRUG:** methylprednisolone(daily scheme)
- **DRUG:** methylprednisolone(weekly scheme)

## Key facts

- **NCT ID:** NCT06510114
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510114, "A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06510114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*